www.biooncology.com/therapeutic-targets/mtor‎CachedSimilarLearn about the mammalian target of rapamycin (mTOR). . cancer therapies.2,3

www.targeting-the-kinome.org/images/thomas2.pdf‎Cachedlie at the crossroads of a nutrient–hormonal signaling network that is involved in

breast-cancer-research.com/content/16/1/R12‎CachedSimilarJan 23, 2014 . Upregulation of PI3K/Akt/mTOR signalling in endocrine-resistant breast cancer (

am.asco.org/mtor-inhibition-small-improvement-pfs-her2-metastatic-breast- cancer-bolero-3‎CachedSimilarJun 3, 2013 . Kimberly L. Blackwell, MD, of the Duke Cancer Institute in Durham, NC, was the

theoncologist.alphamedpress.org/content/13/2/139.fullAmong the possible targets for cancer therapy, the mammalian target of

www.onclive.com/. /A-Tale-of-2-Complexes-The-mTOR-Signaling-Pathway -in-Cancer-Development‎CachedSimilarJun 2, 2011 . In addition, there are many cancer-causing mutations (in tumor suppressors and

www.cancernetwork.com/. cancer/mtor-inhibitors-treatment-breast-cancer‎CachedSimilarJan 15, 2013 . The phosphatidylinositol 3-kinase/mammalian target of rapamycin (PI3K/mTOR)

www.bdbiosciences.com/documents/Grant_Edward_Diaz.pdf‎CachedSimilar2010 Research Grant Program Winning Abstract. Urothelial Cancer Stem Cells

nursing.onclive.com/. /The-Management-of-mTOR-Inhibitor-Side-Effects-in -Breast-Cancer‎CachedSimilarNov 4, 2013 . One facet of the discussion, entitled “Metastatic Breast Cancer . featured

www.ucsf.edu/news/. /cancer-research-shows-promise-new-drugs‎CachedSimilarFeb 22, 2012 . Uncovering the network of genes regulated by a crucial molecule involved in

onlinelibrary.wiley.com/doi/10.1111/bph.12749/abstractJul 25, 2014 . Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and

www.nature.com/nature/journal/v485/n7396/full/nature10912.html‎SimilarMay 3, 2012 . Using ribosome profiling, we uncover specialized translation of the prostate

www.esmo.org/. /Signalling-Pathways-2014-Personalised-Medicine‎CachedThe second ESMO Symposium on Signalling Pathways in Cancer focused on the

www.drugs.com/drug-class/mtor-inhibitors.html‎CachedSimilarMammalian target of rapamycin is a protein kinase, which regulates growth

www.targetmtor.com/‎CachedSimilarLearn about mTOR and how mTOR inhibitors can help to fight cancer through

www.dovepress.com/use-of-mtor-inhibitors-in-the-treatment-of-breast-cancer -an-evaluation-peer-reviewed-article-BCTT‎CachedApr 17, 2014 . This clinically oriented review focuses on the use of mTOR inhibitors in .

www.fiercebiotech.com/story/. pi3kmtor-cancer. /2014-04-08‎CachedApr 8, 2014 . The PI3k/mTOR pathway has attracted considerable attention from developers

www.cancer.gov/cancertopics/understandingcancer/. /breastcancer. /page6‎CachedSimilarDrugs targeting PI3-kinase, Akt, and mTOR are being tested in preclinical models

www.apocpcontrol.org/. /4033-4039%206.2%20Dong%20Han.pdf‎CachedSimilarAsian Pacific Journal of Cancer Prevention, Vol 14, 2013 4033 . LKB1/AMPK/

www.pnas.org/content/104/41/16158.full‎SimilarOct 9, 2007 . Abstract. Side-population (SP) cells within cancers and cell lines are rare cell

www.impactjournals.com/oncotarget/index.php?journal. ‎CachedMaria Giovanna Francipane1,2 and Eric Lagasse1. 1 McGowan Institute for

en.wikipedia.org/wiki/PI3K/AKT/mTOR_pathway‎CachedSimilarThe PI3K/AKT/MTOR pathway is an intracellular signalling pathway important in

www.jnccn.org/content/11/6/670.shortThe Phosphoinositide-3-Kinase-Akt-mTOR Pathway as a Therapeutic Target in .

www.sciencedirect.com/science/article/pii/S1535610807001511‎SimilarJul 9, 2007 . In this review, we discuss recent progress in understanding mTOR signaling,

www.springer.com/biomed/cancer/book/978-1-60327-270-4‎CachedSimilarmTOR Pathway and mTOR Inhibitors in Cancer Therapy provides an up-to-date

erc.endocrinology-journals.org/content/8/3/249.full.pdf‎SimilarThe mammalian target of rapamycin (mTOR) is a central regulator of G1 cell cycle

www.medpagetoday.com/MeetingCoverage/MGUCS/37404‎CachedSimilarFeb 17, 2013 . ORLANDO -- Fatal adverse events occurred more than twice as often in cancer

www.cellsignal.com/common/content/content.jsp?id. mtor. ‎CachedExpert-reviewed pathway providing a current overview of mTOR Signaling, .

www.ncbi.nlm.nih.gov/pubmed/17613433‎SimilarDefining the role of mTOR in cancer. Guertin DA, Sabatini DM. The mammalian

ubcf.info/treating-breast-cancer-targeting-mtor-pathway/‎CachedJul 30, 2014 . new discoveries in treating breast cancer through mTOR Pathway regulated by

www.biomedcentral.com/1471-2407/12/86‎CachedSimilarMar 8, 2012 . The mammalian target of rapamycin (mTOR) is frequently activated in colon

www.jbc.org/content/early/2014/08/20/jbc.M114.592576Aug 20, 2014 . Capsule. Background: Metformin inhibits pancreatic cancer cell and tumor growth

www.ndph.ox.ac.uk/publications/124531‎CachedThe mTOR (mammalian target of rapamycin) signal transduction pathway

www.pri3m.com/targeting-the-pi3k-akt-mtor-pathway.jsp‎CachedIn experimental models, inhibition of the PI3K/AKT/mTOR pathway may halt

cancerdiscovery.aacrjournals.org/content/early/. /2159-8290.CD-13-0353Mar 6, 2014 . Abstract. Understanding the genetic mechanisms of sensitivity to targeted

www.intechopen.com/download/pdf/43352‎CachedSimilarrecent large scale molecular profiling studies in ovarian cancer, such as the

www.medscape.com/viewarticle/827090‎CachedThere are promising data indicating that rapalogs or inhibitors of PI3K/Akt are

www.lillyoncologypipeline.com/Pages/pi3kmtor-dual-inhibitor.aspx‎SimilarThe PI3K/AKT/mTOR pathway is thought to be one of the most frequently . 1 First

journal.frontiersin.org/Journal/10.3389/fonc.2014.00064/abstract‎CachedApr 14, 2014 . The phosphatidylinositol-3-kinase (PI3K)/Akt and the mammalian target of

https://www.scienceopen.com/. /c451f7e5-371b-45e7-a534-deee0c2011bc. pdf‎CachedFeb 10, 2012 . Deregulation of multiple elements of the mTOR pathway (PI3K . and

www.futuremedicine.com/doi/book/10.2217/9781780840642‎SimilarmTOR Inhibitors in Cancer Treatment . Overview and mechanism of action of

cancerdiscovery.aacrjournals.org/content/early/. /2159-8290.CD-13-0929Mar 14, 2014 . Abstract. Genes encoding components of the PI3K-Akt-mTOR signaling axis are

www.mdpi.com/2072-6694/3/2/2478/pdf‎CachedSimilarMay 24, 2011 . patients treated with allosteric mTOR inhibitors such as rapamycin. Despite

www.news-medical.net/. /Mammalian-target-of-rapamycin-(mTOR)-pathway -an-interview-with-Dr-Paul-Mischel-Ludwig-Institute-for-Cancer-Re. ‎CachedSimilarApr 9, 2013 . Thus, mTOR has emerged as a compelling cancer drug target, particularly for

www.nature.com/srep/2013/131115/srep03230/full/srep03230.html‎SimilarNov 15, 2013 . Pancreatic cancer is characterized by near-universal mutations in KRAS. The

www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=5‎CachedTargeting the PI3K-mTOR Network in Cancer. September 14 - 17, 2014.

sabatinilab.wi.mit.edu/. /Guertin-mTOR_rev-TiMM-2005.pdf‎CachedSimilarAn expanding role for mTOR in cancer. David A. Guertin1 and David M. Sabatini1

www.clintransmed.com/content/pdf/2001-1326-1-29.pdf‎CachedSimilarNov 15, 2012 . R E V I E W. Open Access. Rapamycin and mTOR: a serendipitous discovery and

jnci.oxfordjournals.org/content/106/9/dju21514, Section 3, Renmin South Road, Chengdu, Sichuan 610041, China (e-mail:

www.molecular-cancer.com/content/12/1/81‎CachedSimilarJul 25, 2013 . Our data provide a rationale for overcoming radio-resistance by combined with

Sitemap